From: “No generics, Doctor!” The perspective of general practitioners in two French regions
N | % | 95% CI | |
---|---|---|---|
In your routine practice, what are your prescribing choices in regard to generics or originators? (Only one possible answer) | |||
It depends on the situation | 233 | 73.7 | 70.7–76.6 |
I prescribe only generics or by INN a | 50 | 15.8 | 13.5–18.4 |
I prescribe only originators | 33 | 10.4 | 8.4–12.9 |
You answered, “It depends on the situation”. Can you expand on this response? (Several possible answers) | |||
I prescribe an originator if the patient asks for it, even without a reason | 110 | 34.8 | 31.4–38.3 |
A priori, I systematically prescribe an originator for certain drugs | 89 | 28.2 | 25.0–31.5 |
A priori, I systematically prescribe an originator for fragile patients | 61 | 19.3 | 16.6–22.3 |
I prescribe an originator on a case-by-case basis if the patient reports adverse effects | 50 | 15.8 | 13.4–18.6 |
I mainly prescribe by INN a | 36 | 11.4 | 9.3–13.9 |
A priori, I systematically prescribe an originator for certain diseases | 31 | 9.8 | 7.9–12.2 |
I prescribe an originator on a case-by-case basis if I observe adverse effects | 22 | 7.0 | 5.3–9.0 |
I prescribe by INN a with the name of the originator in brackets | 22 | 7.0 | 5.3–9.0 |
I prescribe by INN a or a generic as the initial prescription | 10 | 3.2 | 2.1–4.7 |
I prescribe an originator on a case-by-case basis if the patient says that the generic was not effective | 8 | 2.5 | 1.6–4.0 |
I prescribe an originator on a case-by-case basis if I see that the generic was not effective | 7 | 2.2 | 1.4–3.6 |